Tokushima, Japan

Takafumi Fujiioka

This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takafumi Fujiioka. Retrieved from https://idiyas.com/inventor/takafumi-fujiioka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takafumi Fujiioka: Innovator in Pharmaceutical Chemistry

Introduction

Takafumi Fujiioka is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on carbostyril derivatives. His research has led to advancements in the development of new therapeutic agents.

Latest Patents

Fujiioka holds a patent for "Carbostyril derivatives and pharmaceutical composition containing the." This patent describes novel carbostyril derivatives that exhibit excellent vasopressin antagonistic activities. These compounds are useful as vasodilators, hypotensive agents, water diuretics, and platelet agglutination inhibitors. The patent highlights the potential of these derivatives in treating various medical conditions.

Career Highlights

Fujiioka is associated with Otsuka Pharmaceutical Company, Limited, where he has been instrumental in advancing pharmaceutical research. His work has not only contributed to the company's portfolio but has also had a broader impact on the pharmaceutical industry.

Collaborations

Fujiioka has collaborated with notable colleagues such as Hidenori Ogawa and Hisashi Miyamoto. These collaborations have fostered a productive research environment, leading to innovative solutions in pharmaceutical development.

Conclusion

Takafumi Fujiioka's contributions to pharmaceutical chemistry, particularly through his patented carbostyril derivatives, underscore his role as a key innovator in the field. His work continues to influence the development of new therapeutic agents that can improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…